CN Patent

CN105030777B — 增强alk‑tki疗效、延缓其耐药的复合物及其制剂

Assigned to Third Affiliated Hospital of TMMU · Expires 2017-07-21 · 9y expired

What this patent protects

本发明提供一种水飞蓟宾或其盐和ALK‑TKI的复合物及其用途，该复合物可用于增强ALK‑TKI疗效、延缓其耐药，有效地提高了ALK‑TKI的治疗效果。

USPTO Abstract

本发明提供一种水飞蓟宾或其盐和ALK‑TKI的复合物及其用途，该复合物可用于增强ALK‑TKI疗效、延缓其耐药，有效地提高了ALK‑TKI的治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN105030777B
Jurisdiction
CN
Classification
—
Expires
2017-07-21
Drug substance claim
No
Drug product claim
No
Assignee
Third Affiliated Hospital of TMMU
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.